| Patent(s) and the Corresponding Patented Drug(s) |
Top |
| World Intellectual Property Organization (WIPO) |
| Patent ID |
WO2012053606 |
| Title |
Arylaminoheterocyclic Carboxamide Compound. |
| Applicant(s) |
Astellas Pharma Inc |
| Representative Drug(s) |
D0MX7B |
Drug Info
|
N.A. |
[1] |
| Patent ID |
WO2013116291 |
| Title |
Imidazo [4, 5 - B] Pyridine Derivatives As Alk and Jak Modulators for The Treatment of Proliferative Disorders. |
| Abstract |
This application relates to compounds of the Formula I as defined herein, and/or salts thereof. This application further relates to compositions and methods of using these compounds and/or salts thereof. The compounds of Formula I are useful as ALK and JAK modulators for the treatment of proliferative disorders. |
| Applicant(s) |
Cephalon, Inc |
| Representative Drug(s) |
D0NP2W |
Drug Info
|
IC50 < 100 nM |
[2] |
| Patent ID |
WO2013132376 |
| Title |
Macrocyclic Derivatives for The Treatment of Proliferative Diseases. |
| Abstract |
The invention relates to compounds of formula (Phi) as further defined herein and to the pharmaceutically acceptable salts thereof, to pharmaceutical compositions comprising such compounds and salts, and to the uses thereof. The compounds and salts of the present invention inhibit anaplastic lymphoma kinase (ALK) and/or EML4-ALK and are useful for treating or ameliorating abnormal cell proliferative disorders, such as cancer. |
| Applicant(s) |
Pfizer Inc |
| Representative Drug(s) |
D0N8YJ |
Drug Info
|
N.A. |
[3] |
| Patent ID |
WO2012018668 |
| Title |
Benzimidazole and Azabenzimidazole Compounds That Inhibit Anaplastic Lymphoma Kinase. |
| Abstract |
Compounds of Formula (I) are useful inhibitors of anaplastic lymphoma kinase. Compounds of Formula (I) have the following structure: where the definitions of the variables are provided herein. |
| Applicant(s) |
Amgen, Inc |
| Representative Drug(s) |
D0T3TZ |
Drug Info
|
N.A. |
[3] |
